Here are the latest quarterly results of IPCA Labs. For more details, see the IPCA Labs financial fact sheet and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19 |
3
Jun-19 |
3
Sep-19 |
3
Dec-19 |
3
Mar-20 |
3
Jun-20 |
3
Sep-20 |
3
Dec-20 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 8,338 | 10,110 | 12,126 | 11,391 | 10,048 | 14,853 | 12,978 | 13,152 | |
Other income | Rs m | 146 | 194 | 143 | 176 | 133 | 117 | 150 | 157 | |
Turnover | Rs m | 8,484 | 10,304 | 12,269 | 11,567 | 10,181 | 14,969 | 13,128 | 13,309 | |
Expenses | Rs m | 6,591 | 8,160 | 9,510 | 8,736 | 8,121 | 8,973 | 9,376 | 9,664 | |
Gross profit | Rs m | 1,747 | 1,950 | 2,616 | 2,654 | 1,927 | 5,880 | 3,602 | 3,488 | |
Depreciation | Rs m | 416 | 420 | 451 | 462 | 454 | 452 | 463 | 477 | |
Interest | Rs m | 63 | 45 | 41 | 38 | 35 | 25 | 18 | 16 | |
Profit before tax | Rs m | 1,414 | 1,680 | 2,267 | 2,331 | 1,572 | 5,519 | 3,271 | 3,153 | |
Tax | Rs m | 319 | 359 | 307 | 365 | 294 | 983 | 514 | 553 | |
Profit after tax | Rs m | 1,095 | 1,321 | 1,960 | 1,966 | 1,278 | 4,536 | 2,757 | 2,600 | |
Gross profit margin | % | 20.9 | 19.3 | 21.6 | 23.3 | 19.2 | 39.6 | 27.8 | 26.5 | |
Effective tax rate | % | 22.6 | 21.4 | 13.5 | 15.6 | 18.7 | 17.8 | 15.7 | 17.5 | |
Net profit margin | % | 13.1 | 13.1 | 16.2 | 17.3 | 12.7 | 30.5 | 21.2 | 19.8 | |
Diluted EPS | Rs | 8.7 | 10.5 | 15.5 | 15.6 | 10.1 | 35.9 | 21.8 | 20.6 | |
Diluted EPS (TTM) | Rs | 36.0 | 41.3 | 47.4 | 50.3 | 51.7 | 77.2 | 83.5 | 88.5 | |
![]() |
Read: IPCA Labs 3QFY21 Result Performance Review
More Pharmaceuticals Company Quarterly Results: ALKEM LABORATORIES WYETH SANOFI INDIA BIOCON WOCKHARDT
Compare IPCA LABS With: ALKEM LABORATORIES WYETH SANOFI INDIA BIOCON WOCKHARDT
Compare IPCA LABS With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
This ignored sector could deliver big short-term profits.
More